The Ensign Group, Inc. $ENSG Stake Lessened by Segall Bryant & Hamill LLC

Segall Bryant & Hamill LLC cut its stake in The Ensign Group, Inc. (NASDAQ:ENSG) by 7.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 315,719 shares of the company’s stock after selling 25,131 shares during the period. The Ensign Group accounts for 0.8% of Segall Bryant & Hamill LLC’s portfolio, making the stock its 11th largest position. Segall Bryant & Hamill LLC’s holdings in The Ensign Group were worth $63,617,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in ENSG. Argent Capital Management LLC grew its holdings in The Ensign Group by 37.2% during the 1st quarter. Argent Capital Management LLC now owns 7,640 shares of the company’s stock worth $1,539,000 after acquiring an additional 2,073 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of The Ensign Group by 2.7% in the 1st quarter. Janus Henderson Group PLC now owns 35,859 shares of the company’s stock valued at $7,228,000 after purchasing an additional 941 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of The Ensign Group by 30.5% in the 1st quarter. EverSource Wealth Advisors LLC now owns 992 shares of the company’s stock valued at $200,000 after purchasing an additional 232 shares in the last quarter. California State Teachers Retirement System lifted its position in shares of The Ensign Group by 23.0% during the first quarter. California State Teachers Retirement System now owns 67,358 shares of the company’s stock worth $13,573,000 after purchasing an additional 12,575 shares during the last quarter. Finally, Eversept Partners LP bought a new position in shares of The Ensign Group during the first quarter worth about $2,974,000. 96.12% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Barry M. Smith sold 700 shares of the stock in a transaction that occurred on Tuesday, June 2nd. The stock was sold at an average price of $164.28, for a total transaction of $114,996.00. Following the sale, the director directly owned 21,352 shares in the company, valued at approximately $3,507,706.56. This represents a 3.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the firm’s stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $171.06, for a total value of $67,055.52. Following the completion of the sale, the director directly owned 9,503 shares in the company, valued at approximately $1,625,583.18. This trade represents a 3.96% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,792 shares of company stock valued at $309,599. 4.00% of the stock is currently owned by insiders.

The Ensign Group Stock Down 0.4%

Shares of NASDAQ:ENSG opened at $178.16 on Friday. The company’s fifty day moving average is $165.81 and its two-hundred day moving average is $183.96. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.56 and a current ratio of 1.21. The Ensign Group, Inc. has a 1-year low of $141.58 and a 1-year high of $218.00. The stock has a market capitalization of $10.38 billion, a price-to-earnings ratio of 27.92, a price-to-earnings-growth ratio of 1.72 and a beta of 0.69.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Monday, July 27th. The company reported $1.92 EPS for the quarter, beating the consensus estimate of $1.80 by $0.12. The Ensign Group had a net margin of 6.90% and a return on equity of 16.75%. The business had revenue of $1.44 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period in the previous year, the business posted $1.59 EPS. The company’s quarterly revenue was up 16.7% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.750-7.850 EPS. Equities analysts anticipate that The Ensign Group, Inc. will post 6.93 EPS for the current year.

The Ensign Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, July 31st. Shareholders of record on Tuesday, June 30th were paid a $0.065 dividend. This represents a $0.26 dividend on an annualized basis and a yield of 0.1%. The ex-dividend date was Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

Analyst Ratings Changes

A number of research firms recently commented on ENSG. Royal Bank Of Canada reiterated an “outperform” rating and issued a $228.00 price target on shares of The Ensign Group in a research note on Tuesday. Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, June 16th. Truist Financial increased their target price on The Ensign Group from $202.00 to $207.00 and gave the stock a “hold” rating in a report on Thursday. Zacks Research lowered The Ensign Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Finally, Wall Street Zen downgraded The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday, July 25th. Four research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $216.25.

The Ensign Group Company Profile

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.